• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

SharpLink Resumes Ethereum Accumulation After Eight-Month Pause

chest

SharpLink has resumed its Ethereum accumulation after an eight-month pause, acquiring 5,000 ETH worth approximately $7.85 million through FalconX.

user avatarZainab Kamara

Cryptonews Implements Strict Editorial Policy

chest

Cryptonews has recently established a strict editorial policy that focuses on accuracy, relevance, and impartiality.

user avatarSon Min-ho

Bithumb Fined 210 Million Won for Data Transfer Violations

chest

Bithumb was fined 210 million won for sharing user data without proper consent.

user avatarAyman Ben Youssef

BEA Releases May 2026 PCE Data

chest

The Bureau of Economic Analysis (BEA) has published the Personal Consumption Expenditures (PCE) data for May 2026, providing updated insights into consumer spending and economic trends.

user avatarTando Nkube

ARK Invest Boosts Holdings in Crypto-Linked Stocks Amid Market Pullback

chest

ARK Invest has increased its holdings in regulated crypto-linked stocks during a market pullback, reflecting a strategy to maintain exposure to public crypto infrastructure.

user avatarKofi Adjeman

Risks in the AI Market Amidst Stock Surge

chest

Experts warn of potential risks in the AI stock market, drawing parallels to the late 1990s dot-com bubble.

user avatarSatoshi Nakamura

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.